ClinConnect ClinConnect Logo
Search / Trial NCT06708676

Washed Microbiota Transplantation in Solid Organ Transplantation

Launched by THE SECOND HOSPITAL OF NANJING MEDICAL UNIVERSITY · Nov 24, 2024

Trial Information

Current as of July 09, 2025

Not yet recruiting

Keywords

Solid Organ Transplant Complications Washed Microbiota Transplantation Fecal Microbiota Transplantation Diarrhea Clostridium Difficile

ClinConnect Summary

This clinical trial is investigating a new treatment called washed microbiota transplantation (WMT) to help patients who have received solid organ transplants, like kidneys or livers, and are experiencing complications such as gastrointestinal issues, infections, or graft rejection. These complications can be serious and affect the success of the transplant and the patient's overall health. The researchers believe that restoring the balance of healthy bacteria in the gut may improve these issues, as many transplant patients often struggle with gut health due to medications and other factors.

To be eligible for this trial, participants must be recipients of a solid organ transplant and experiencing specific problems like diarrhea, infections, or signs of graft rejection. They also need to be willing to undergo the WMT procedure and provide consent. The trial is not yet recruiting, meaning it hasn't started accepting participants yet. If you or a loved one qualifies, you can expect to receive the new treatment and be closely monitored by the study team to assess how well it works and if it is safe. It's an exciting opportunity that could potentially lead to better care for those facing complications after a transplant.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. solid organ transplantation recipients;
  • 2. suffering from gastrointestinal symptoms (e.g. diarrhea, constipation, abdominal pian), infection (e.g. Clostridium difficile, urinary infection) post-transplantation, graft rejection and so on;
  • 3. is willing to undergo WMT and provide written informed consent;
  • Exclusion Criteria:
  • 1. patients with history of gastrointestinal diseases or homologous pathogen infection pre-transplant;
  • 2. pregnant or lactating females;
  • 3. unable to understand the purpose of the study, communicate effectively with investigators and comply with all study procedures;
  • 4. follow up less than 1-month post-WMT;
  • 5. other conditions judged by investigators not suitable for study participation;

About The Second Hospital Of Nanjing Medical University

The Second Hospital of Nanjing Medical University is a leading clinical research institution dedicated to advancing healthcare through innovative research and rigorous clinical trials. Affiliated with Nanjing Medical University, the hospital is equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals. The institution focuses on a wide range of medical specialties, aiming to enhance patient care and treatment outcomes by evaluating new therapies and interventions. Committed to ethical research practices and patient safety, the Second Hospital of Nanjing Medical University plays a pivotal role in contributing to the scientific community and improving public health.

Locations

Nanjing, Jiangsu, China

Patients applied

0 patients applied

Trial Officials

Faming Zhang, PhD

Principal Investigator

The Second Hospital of Nanjing Medical University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported